Evidence map›Paper›PMID 33671329›Full record

ReviewPolymers2021

Collagen Type I Biomaterials as Scaffolds for Bone Tissue Engineering.

Gustavo A Rico-Llanos, Sara Borrego-González, Miguelangel Moncayo-Donoso, José Becerra, Rick Visser

Open access · goldAbstract readReview
In one paragraph

Review in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 223 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Dual ROS modulation by MnOTheranostics · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Gustavo A Rico-LlanosDepartment of Cell Biology, Genetics and Physiology, Faculty of Science, University of Málaga, IBIMA, 29071 Málaga, Spain.ORCID 0000-0001-5991-848X
Sara Borrego-GonzálezAndalusian Center for Nanomedicine and Biotechnology (BIONAND), 29590 Málaga, Spain.
Miguelangel Moncayo-DonosoAndalusian Center for Nanomedicine and Biotechnology (BIONAND), 29590 Málaga, Spain.
José BecerraDepartment of Cell Biology, Genetics and Physiology, Faculty of Science, University of Málaga, IBIMA, 29071 Málaga, Spain.ORCID 0000-0002-4849-8931
Rick VisserDepartment of Cell Biology, Genetics and Physiology, Faculty of Science, University of Málaga, IBIMA, 29071 Málaga, Spain.
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESInstituto de Ciencia de Materiales de Sevilla · ESUniversidad Nacional de Colombia · CO

Funding

Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina CB06/01/1015Junta de Andalucía BIO-217Ministerio de Economía, Industria y Competitividad, Gobierno de España BIO2015-66266Red Española de Terapia Celular RD16/0011/0022
6 · The paper itself

Abstract

Collagen type I is the main organic constituent of the bone extracellular matrix and has been used for decades as scaffolding material in bone tissue engineering approaches when autografts are not feasible. Polymeric collagen can be easily isolated from various animal sources and can be processed in a great number of ways to manufacture biomaterials in the form of sponges, particles, or hydrogels, among others, for different applications. Despite its great biocompatibility and osteoconductivity, collagen type I also has some drawbacks, such as its high biodegradability, low mechanical strength, and lack of osteoinductive activity. Therefore, many attempts have been made to improve the collagen type I-based implants for bone tissue engineering. This review aims to summarize the current status of collagen type I as a biomaterial for bone tissue engineering, as well as to highlight some of the main efforts that have been made recently towards designing and producing collagen implants to improve bone regeneration.

Indexed as

bone tissue engineeringcollagengrowth factorspeptidesscaffolds

Identifiers

PMID33671329
PMCPMC7923188
OpenAlexW3130148755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.